{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T15:46:34Z","timestamp":1772034394080,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T00:00:00Z","timestamp":1600041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T00:00:00Z","timestamp":1600041600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"crossref","award":["NRF-2016R1D1A1B03934110"],"award-info":[{"award-number":["NRF-2016R1D1A1B03934110"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"crossref","award":["NRF-2018R1A2B6002920"],"award-info":[{"award-number":["NRF-2018R1A2B6002920"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation, Korea","doi-asserted-by":"crossref","award":["2017R1A2B2008408"],"award-info":[{"award-number":["2017R1A2B2008408"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"crossref","award":["KHIDI, HI14C0072"],"award-info":[{"award-number":["KHIDI, HI14C0072"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Salivary duct carcinoma (SDC) is one of the most aggressive subtypes of salivary gland cancers. Conventional chemotherapy and\/or radiation have shown only limited clinical efficacy in the treatment of recurrent or metastatic SDC. Currently, clinically approved targeted-therapeutics are not generally applicable except in very limited cases, and there exists a strong need for the development of treatment against this unique tumor type. To further interrogate genomic features of SDC, we have conducted multi-omic profiling of the SDC to describe the genomic alterations prevalent in this disease. Whole-genome sequencing, whole exome-sequencing and transcriptome sequencing were performed on a discovery cohort of 10 SDC samples. Targeted genomic profiling was performed in additional 32 SDC samples to support the findings obtained from the original discovery cohort. The cancer cohort was characterized by an average mutation burden of 85 somatic exonic mutations per tumor sample. The cohort harbored a mutational signature of BRCA and APOBEC\/AID. Several genes, including <jats:italic>TP53<\/jats:italic>, <jats:italic>RB1<\/jats:italic>, <jats:italic>SMAD4<\/jats:italic>, <jats:italic>HRAS<\/jats:italic>, <jats:italic>APC<\/jats:italic>, <jats:italic>PIK3CA<\/jats:italic> and <jats:italic>GNAQ<\/jats:italic> were recurrently somatically altered in SDC. A novel fusion gene, generated by genomic rearrangement, <jats:italic>MYB-NHSL1<\/jats:italic>, was also noted. Our findings represent a significant layer in the systematic understanding of potentially clinically useful genomic and molecular targets for a subset of recurrent\/metastatic SDC.<\/jats:p>","DOI":"10.1038\/s41598-020-72096-2","type":"journal-article","created":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T10:03:01Z","timestamp":1600077781000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Integrative genomic analysis of salivary duct carcinoma"],"prefix":"10.1038","volume":"10","author":[{"given":"Youngwook","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanghoon","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miran","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Swatloski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joon Ho","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young-Hyeh","family":"Ko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Woong-Yang","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han-Sin","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keunchil","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,14]]},"reference":[{"key":"72096_CR1","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1002\/(SICI)1097-0347(199703)19:2<126::AID-HED7>3.0.CO;2-6","volume":"19","author":"M Guzzo","year":"1997","unstructured":"Guzzo, M., Di Palma, S., Grandi, C. & Molinari, R. Salivary duct carcinoma: clinical characteristics and treatment strategies. Head Neck 19, 126\u2013133 (1997).","journal-title":"Head Neck"},{"key":"72096_CR2","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/j.oraloncology.2012.05.004","volume":"48","author":"A Lagha","year":"2012","unstructured":"Lagha, A. et al. Systemic therapy in the management of metastatic or advanced salivary gland cancers. Oral Oncol. 48, 948\u2013957. https:\/\/doi.org\/10.1016\/j.oraloncology.2012.05.004 (2012).","journal-title":"Oral Oncol."},{"key":"72096_CR3","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1043\/1543-2165-133.11.1763","volume":"133","author":"JB McHugh","year":"2009","unstructured":"McHugh, J. B., Visscher, D. W. & Barnes, E. L. Update on selected salivary gland neoplasms. Arch. Pathol. Lab. Med. 133, 1763\u20131774. https:\/\/doi.org\/10.1043\/1543-2165-133.11.1763 (2009).","journal-title":"Arch. Pathol. Lab. Med."},{"key":"72096_CR4","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1097\/00000478-200004000-00014","volume":"24","author":"CY Fan","year":"2000","unstructured":"Fan, C. Y., Wang, J. & Barnes, E. L. Expression of androgen receptor and prostatic specific markers in salivary duct carcinoma: an immunohistochemical analysis of 13 cases and review of the literature. Am. J. Surg. Pathol. 24, 579\u2013586 (2000).","journal-title":"Am. J. Surg. Pathol."},{"key":"72096_CR5","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1097\/PAS.0b013e3180caa099","volume":"31","author":"MD Williams","year":"2007","unstructured":"Williams, M. D. et al. Differential expression of hormonal and growth factor receptors in salivary duct carcinomas: biologic significance and potential role in therapeutic stratification of patients. Am. J. Surg. Pathol. 31, 1645\u20131652. https:\/\/doi.org\/10.1097\/PAS.0b013e3180caa099 (2007).","journal-title":"Am. J. Surg. Pathol."},{"key":"72096_CR6","doi-asserted-by":"publisher","first-page":"e473","DOI":"10.1200\/JCO.2010.32.8351","volume":"29","author":"HC Jaspers","year":"2011","unstructured":"Jaspers, H. C. et al. Androgen receptor-positive salivary duct carcinoma: a disease entity with promising new treatment options. J. Clin. Oncol. 29, e473-476. https:\/\/doi.org\/10.1200\/JCO.2010.32.8351 (2011).","journal-title":"J. Clin. Oncol."},{"key":"72096_CR7","doi-asserted-by":"publisher","first-page":"E4","DOI":"10.1002\/hed.23383","volume":"36","author":"MS Soper","year":"2014","unstructured":"Soper, M. S., Iganej, S. & Thompson, L. D. Definitive treatment of androgen receptor-positive salivary duct carcinoma with androgen deprivation therapy and external beam radiotherapy. Head Neck 36, E4-7. https:\/\/doi.org\/10.1002\/hed.23383 (2014).","journal-title":"Head Neck"},{"key":"72096_CR8","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1097\/PAT.0b013e3283484a60","volume":"43","author":"TS Clauditz","year":"2011","unstructured":"Clauditz, T. S. et al. Human epidermal growth factor receptor 2 (HER2) in salivary gland carcinomas. Pathology 43, 459\u2013464. https:\/\/doi.org\/10.1097\/PAT.0b013e3283484a60 (2011).","journal-title":"Pathology"},{"key":"72096_CR9","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1158\/1078-0432.CCR-03-0253","volume":"10","author":"B Glisson","year":"2004","unstructured":"Glisson, B. et al. HER2 expression in salivary gland carcinomas: dependence on histological subtype. Clin. Cancer Res. 10, 944\u2013946 (2004).","journal-title":"Clin. Cancer Res."},{"key":"72096_CR10","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1634\/theoncologist.2012-0369","volume":"18","author":"SA Limaye","year":"2013","unstructured":"Limaye, S. A. et al. Trastuzumab for the treatment of salivary duct carcinoma. Oncologist 18, 294\u2013300. https:\/\/doi.org\/10.1634\/theoncologist.2012-0369 (2013).","journal-title":"Oncologist"},{"key":"72096_CR11","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1002\/hed.20714","volume":"30","author":"A Prat","year":"2008","unstructured":"Prat, A. et al. Successful treatment of pulmonary metastatic salivary ductal carcinoma with trastuzumab-based therapy. Head Neck 30, 680\u2013683. https:\/\/doi.org\/10.1002\/hed.20714 (2008).","journal-title":"Head Neck"},{"key":"72096_CR12","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1200\/JCO.18.00545","volume":"37","author":"H Takahashi","year":"2019","unstructured":"Takahashi, H. et al. Phase II trial of trastuzumab and docetaxel in patients with human epidermal growth factor receptor 2-positive salivary duct carcinoma. J. Clin. Oncol. 37, 125\u2013134. https:\/\/doi.org\/10.1200\/JCO.18.00545 (2019).","journal-title":"J. Clin. Oncol."},{"key":"72096_CR13","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1097\/PAS.0b013e3182880d5a","volume":"37","author":"CC Griffith","year":"2013","unstructured":"Griffith, C. C., Seethala, R. R., Luvison, A., Miller, M. & Chiosea, S. I. PIK3CA mutations and PTEN loss in salivary duct carcinomas. Am. J. Surg. Pathol. 37, 1201\u20131207. https:\/\/doi.org\/10.1097\/PAS.0b013e3182880d5a (2013).","journal-title":"Am. J. Surg. Pathol."},{"key":"72096_CR14","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1016\/S0046-8177(99)90044-8","volume":"30","author":"LA Cerilli","year":"1999","unstructured":"Cerilli, L. A. et al. Analysis of chromosome 9p21 deletion and p16 gene mutation in salivary gland carcinomas. Hum. Pathol. 30, 1242\u20131246 (1999).","journal-title":"Hum. Pathol."},{"key":"72096_CR15","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1097\/PAS.0000000000000410","volume":"39","author":"SI Chiosea","year":"2015","unstructured":"Chiosea, S. I. et al. Molecular characterization of apocrine salivary duct carcinoma. Am. J. Surg. Pathol. 39, 744\u2013752. https:\/\/doi.org\/10.1097\/PAS.0000000000000410 (2015).","journal-title":"Am. J. Surg. Pathol."},{"key":"72096_CR16","doi-asserted-by":"publisher","first-page":"4623","DOI":"10.1158\/1078-0432.CCR-16-0637","volume":"22","author":"MG Dalin","year":"2016","unstructured":"Dalin, M. G. et al. Comprehensive molecular characterization of salivary duct carcinoma reveals actionable targets and similarity to apocrine breast cancer. Clin. Cancer Res. 22, 4623\u20134633. https:\/\/doi.org\/10.1158\/1078-0432.CCR-16-0637 (2016).","journal-title":"Clin. Cancer Res."},{"key":"72096_CR17","first-page":"173","volume-title":"Salivary Duct Carcinoma","author":"T Nagao","year":"2017","unstructured":"Nagao, T., Licitra, L., Loening, T., Vielh, P. & Williams, M. D. Salivary Duct Carcinoma 4th edn, 173\u2013174 (IARC, Lyon, 2017).","edition":"4"},{"key":"72096_CR18","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1186\/s12967-014-0299-6","volume":"12","author":"BM Ku","year":"2014","unstructured":"Ku, B. M. et al. High-throughput profiling identifies clinically actionable mutations in salivary duct carcinoma. J. Transl. Med. 12, 299. https:\/\/doi.org\/10.1186\/s12967-014-0299-6 (2014).","journal-title":"J. Transl. Med."},{"key":"72096_CR19","doi-asserted-by":"publisher","first-page":"e131","DOI":"10.1093\/nar\/gkw520","volume":"44","author":"R Shen","year":"2016","unstructured":"Shen, R. & Seshan, V. E. FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing. Nucleic Acids Res. 44, e131. https:\/\/doi.org\/10.1093\/nar\/gkw520 (2016).","journal-title":"Nucleic Acids Res."},{"key":"72096_CR20","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1093\/bioinformatics\/btu174","volume":"30","author":"Y Li","year":"2014","unstructured":"Li, Y. & Xie, X. Deconvolving tumor purity and ploidy by integrating copy number alterations and loss of heterozygosity. Bioinformatics 30, 2121\u20132129. https:\/\/doi.org\/10.1093\/bioinformatics\/btu174 (2014).","journal-title":"Bioinformatics"},{"key":"72096_CR21","doi-asserted-by":"publisher","first-page":"R41","DOI":"10.1186\/gb-2011-12-4-r41","volume":"12","author":"CH Mermel","year":"2011","unstructured":"Mermel, C. H. et al. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol. 12, R41. https:\/\/doi.org\/10.1186\/gb-2011-12-4-r41 (2011).","journal-title":"Genome Biol."},{"key":"72096_CR22","doi-asserted-by":"publisher","first-page":"i333","DOI":"10.1093\/bioinformatics\/bts378","volume":"28","author":"T Rausch","year":"2012","unstructured":"Rausch, T. et al. DELLY: structural variant discovery by integrated paired-end and split-read analysis. Bioinformatics 28, i333\u2013i339. https:\/\/doi.org\/10.1093\/bioinformatics\/bts378 (2012).","journal-title":"Bioinformatics"},{"key":"72096_CR23","doi-asserted-by":"publisher","first-page":"e1001138","DOI":"10.1371\/journal.pcbi.1001138","volume":"7","author":"A McPherson","year":"2011","unstructured":"McPherson, A. et al. deFuse: an algorithm for gene fusion discovery in tumor RNA-Seq data. PLoS Comput. Biol. 7, e1001138. https:\/\/doi.org\/10.1371\/journal.pcbi.1001138 (2011).","journal-title":"PLoS Comput. Biol."},{"key":"72096_CR24","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1093\/bioinformatics\/btr310","volume":"27","author":"H Ge","year":"2011","unstructured":"Ge, H. et al. FusionMap: detecting fusion genes from next-generation sequencing data at base-pair resolution. Bioinformatics 27, 1922\u20131928. https:\/\/doi.org\/10.1093\/bioinformatics\/btr310 (2011).","journal-title":"Bioinformatics"},{"key":"72096_CR25","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.1093\/bioinformatics\/btr467","volume":"27","author":"MK Iyer","year":"2011","unstructured":"Iyer, M. K., Chinnaiyan, A. M. & Maher, C. A. ChimeraScan: a tool for identifying chimeric transcription in sequencing data. Bioinformatics 27, 2903\u20132904. https:\/\/doi.org\/10.1093\/bioinformatics\/btr467 (2011).","journal-title":"Bioinformatics"},{"key":"72096_CR26","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/nprot.2012.016","volume":"7","author":"C Trapnell","year":"2012","unstructured":"Trapnell, C. et al. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat. Protoc. 7, 562\u2013578. https:\/\/doi.org\/10.1038\/nprot.2012.016 (2012).","journal-title":"Nat. Protoc."},{"key":"72096_CR27","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman, A. M. et al. Robust enumeration of cell subsets from tissue expression profiles. Nat. Methods 12, 453\u2013457. https:\/\/doi.org\/10.1038\/nmeth.3337 (2015).","journal-title":"Nat. Methods"},{"key":"72096_CR28","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1093\/bioinformatics\/btr446","volume":"27","author":"K Cibulskis","year":"2011","unstructured":"Cibulskis, K. et al. ContEst: estimating cross-contamination of human samples in next-generation sequencing data. Bioinformatics 27, 2601\u20132602. https:\/\/doi.org\/10.1093\/bioinformatics\/btr446 (2011).","journal-title":"Bioinformatics"},{"key":"72096_CR29","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nature12213","volume":"499","author":"MS Lawrence","year":"2013","unstructured":"Lawrence, M. S. et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature 499, 214\u2013218. https:\/\/doi.org\/10.1038\/nature12213 (2013).","journal-title":"Nature"},{"key":"72096_CR30","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13059-016-0893-4","volume":"17","author":"R Rosenthal","year":"2016","unstructured":"Rosenthal, R., McGranahan, N., Herrero, J., Taylor, B. S. & Swanton, C. DeconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution. Genome Biol. 17, 31. https:\/\/doi.org\/10.1186\/s13059-016-0893-4 (2016).","journal-title":"Genome Biol."},{"key":"72096_CR31","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nature12477","volume":"500","author":"LB Alexandrov","year":"2013","unstructured":"Alexandrov, L. B. et al. Signatures of mutational processes in human cancer. Nature 500, 415\u2013421. https:\/\/doi.org\/10.1038\/nature12477 (2013).","journal-title":"Nature"},{"key":"72096_CR32","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.celrep.2012.12.008","volume":"3","author":"LB Alexandrov","year":"2013","unstructured":"Alexandrov, L. B., Nik-Zainal, S., Wedge, D. C., Campbell, P. J. & Stratton, M. R. Deciphering signatures of mutational processes operative in human cancer. Cell Rep. 3, 246\u2013259. https:\/\/doi.org\/10.1016\/j.celrep.2012.12.008 (2013).","journal-title":"Cell Rep."},{"key":"72096_CR33","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/nrg3729","volume":"15","author":"T Helleday","year":"2014","unstructured":"Helleday, T., Eshtad, S. & Nik-Zainal, S. Mechanisms underlying mutational signatures in human cancers. Nat. Rev. Genet. 15, 585\u2013598. https:\/\/doi.org\/10.1038\/nrg3729 (2014).","journal-title":"Nat. Rev. Genet."},{"key":"72096_CR34","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1038\/ng.3934","volume":"49","author":"P Polak","year":"2017","unstructured":"Polak, P. et al. A mutational signature reveals alterations underlying deficient homologous recombination repair in breast cancer. Nat. Genet. 49, 1476\u20131486. https:\/\/doi.org\/10.1038\/ng.3934 (2017).","journal-title":"Nat. Genet."},{"key":"72096_CR35","doi-asserted-by":"publisher","first-page":"6274","DOI":"10.1093\/nar\/gkw491","volume":"44","author":"R Xi","year":"2016","unstructured":"Xi, R., Lee, S., Xia, Y., Kim, T. M. & Park, P. J. Copy number analysis of whole-genome data using BIC-seq2 and its application to detection of cancer susceptibility variants. Nucleic Acids Res. 44, 6274\u20136286. https:\/\/doi.org\/10.1093\/nar\/gkw491 (2016).","journal-title":"Nucleic Acids Res."},{"key":"72096_CR36","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S1525-1578(10)60511-9","volume":"6","author":"C Martins","year":"2004","unstructured":"Martins, C. et al. A study of MECT1-MAML2 in mucoepidermoid carcinoma and Warthin\u2019s tumor of salivary glands. J. Mol. Diagn. 6, 205\u2013210. https:\/\/doi.org\/10.1016\/S1525-1578(10)60511-9 (2004).","journal-title":"J. Mol. Diagn."},{"key":"72096_CR37","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1097\/PAS.0b013e3182002777","volume":"35","author":"RB West","year":"2011","unstructured":"West, R. B. et al. MYB expression and translocation in adenoid cystic carcinomas and other salivary gland tumors with clinicopathologic correlation. Am. J. Surg. Pathol. 35, 92\u201399. https:\/\/doi.org\/10.1097\/PAS.0b013e3182002777 (2011).","journal-title":"Am. J. Surg. Pathol."},{"key":"72096_CR38","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1097\/PAS.0b013e3181d9efcc","volume":"34","author":"A Skalova","year":"2010","unstructured":"Skalova, A. et al. Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity. Am. J. Surg. Pathol. 34, 599\u2013608. https:\/\/doi.org\/10.1097\/PAS.0b013e3181d9efcc (2010).","journal-title":"Am. J. Surg. Pathol."},{"key":"72096_CR39","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1002\/gcc.20881","volume":"50","author":"CR Antonescu","year":"2011","unstructured":"Antonescu, C. R. et al. EWSR1-ATF1 fusion is a novel and consistent finding in hyalinizing clear-cell carcinoma of salivary gland. Genes Chromosomes Cancer 50, 559\u2013570. https:\/\/doi.org\/10.1002\/gcc.20881 (2011).","journal-title":"Genes Chromosomes Cancer"},{"key":"72096_CR40","doi-asserted-by":"publisher","first-page":"18740","DOI":"10.1073\/pnas.0909114106","volume":"106","author":"M Persson","year":"2009","unstructured":"Persson, M. et al. Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck. Proc. Natl. Acad. Sci. U. S. A. 106, 18740\u201318744. https:\/\/doi.org\/10.1073\/pnas.0909114106 (2009).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"72096_CR41","doi-asserted-by":"publisher","first-page":"e111","DOI":"10.1158\/0008-5472.CAN-17-0580","volume":"77","author":"Y Newton","year":"2017","unstructured":"Newton, Y. et al. TumorMap: exploring the molecular similarities of cancer samples in an interactive portal. Cancer Res. 77, e111\u2013e114. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-0580 (2017).","journal-title":"Cancer Res."},{"key":"72096_CR42","doi-asserted-by":"publisher","first-page":"6061","DOI":"10.1158\/1078-0432.CCR-15-2568","volume":"22","author":"K Wang","year":"2016","unstructured":"Wang, K. et al. Profiling of 149 salivary duct carcinomas, carcinoma ex pleomorphic adenomas, and adenocarcinomas, not otherwise specified reveals actionable genomic alterations. Clin. Cancer Res. 22, 6061\u20136068. https:\/\/doi.org\/10.1158\/1078-0432.CCR-15-2568 (2016).","journal-title":"Clin. Cancer Res."},{"key":"72096_CR43","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1093\/annonc\/mdx399","volume":"28","author":"JS Ross","year":"2017","unstructured":"Ross, J. S. et al. Comprehensive genomic profiles of metastatic and relapsed salivary gland carcinomas are associated with tumor type and reveal new routes to targeted therapies. Ann. Oncol. 28, 2539\u20132546. https:\/\/doi.org\/10.1093\/annonc\/mdx399 (2017).","journal-title":"Ann. Oncol."},{"key":"72096_CR44","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1056\/NEJMoa1406498","volume":"371","author":"A Snyder","year":"2014","unstructured":"Snyder, A. et al. Genetic basis for clinical response to CTLA-4 blockade in melanoma. N. Engl. J. Med. 371, 2189\u20132199. https:\/\/doi.org\/10.1056\/NEJMoa1406498 (2014).","journal-title":"N. Engl. J. Med."},{"key":"72096_CR45","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1126\/science.aad0095","volume":"350","author":"EM Van Allen","year":"2015","unstructured":"Van Allen, E. M. et al. Genomic correlates of response to CTLA-4 blockade in metastatic melanoma. Science 350, 207\u2013211. https:\/\/doi.org\/10.1126\/science.aad0095 (2015).","journal-title":"Science"},{"key":"72096_CR46","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1126\/science.aaa1348","volume":"348","author":"NA Rizvi","year":"2015","unstructured":"Rizvi, N. A. et al. Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer. Science 348, 124\u2013128. https:\/\/doi.org\/10.1126\/science.aaa1348 (2015).","journal-title":"Science"},{"key":"72096_CR47","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1200\/JCO.2013.50.8556","volume":"32","author":"Y Kim","year":"2014","unstructured":"Kim, Y. et al. Integrative and comparative genomic analysis of lung squamous cell carcinomas in East Asian patients. J. Clin. Oncol. 32, 121\u2013128. https:\/\/doi.org\/10.1200\/JCO.2013.50.8556 (2014).","journal-title":"J. Clin. Oncol."},{"key":"72096_CR48","doi-asserted-by":"publisher","first-page":"40491","DOI":"10.18632\/oncotarget.9636","volume":"7","author":"S Yao","year":"2016","unstructured":"Yao, S. et al. Differences in somatic mutation landscape of hepatocellular carcinoma in Asian American and European American populations. Oncotarget 7, 40491\u201340499. https:\/\/doi.org\/10.18632\/oncotarget.9636 (2016).","journal-title":"Oncotarget"},{"key":"72096_CR49","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1093\/annonc\/mdx771","volume":"29","author":"C Fushimi","year":"2018","unstructured":"Fushimi, C. et al. A prospective phase II study of combined androgen blockade in patients with androgen receptor-positive metastatic or locally advanced unresectable salivary gland carcinoma. Ann. Oncol. 29, 979\u2013984. https:\/\/doi.org\/10.1093\/annonc\/mdx771 (2018).","journal-title":"Ann. Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72096-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72096-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72096-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T19:21:01Z","timestamp":1670354461000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72096-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,14]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["72096"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-72096-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,14]]},"assertion":[{"value":"31 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14995"}}